Formulation and Evaluation of Sustained Release Matrix Tablets of Isoxsuprine Hydrochloride by Direct Compression Method
A sustained-release tablet formulation should ideally have a proper release profile insensitive to moderate changes in tablet hardness that is usually encountered in manufacturing. Isoxsuprine hydrochloride is structurally a novel vasodilator. The short biological half-life (5±2 hr) and the fast clearance make the drug, a suitable candidate for the development of modified release formulation. A novel oral controlled delivery system for isoxsuprine hydrochloride was developed and optimized. Matrix tablets of isoxsuprine hydrochloride were prepared by using hydroxypropylmethylcellulose (HPMC K15), Gaur Gum and PVP K 30 as polymer substance to achieve required sustained release profile. The matrix tablets were prepared by direct compression method which is now days considered a cost effective and simple method of manufacturing. It is considered as an appropriate method for hygroscopic and thermolabile substances. Six formulations of different polymer percentages were formulated (F1-F6). Pre-compression parameters were evaluated. The influence of matrix forming agents and binary mixtures of them on isoxsuprine hydrochloride release was investigated. The formulated tablets were characterized by hardness, friability, thickness, weight variation and in vitro drug release. The formulated tablets had acceptable physicochemical characters. There was no chemical interaction found between the drug and excipients throughout FT-IR and UV study thought of in the present investigation. The quantity of isoxsuprine hydrochloride present in the tablets and the release medium were estimated by a simple, rapid and validated UV method. The dissolution results show that increased amount of polymer resulted in reduced and extended drug release. F4 formulation is the optimum formulation due to its better targeting profile in terms of release. First order kinetic profiles were achieved. This formulation may provide an alternative for oral controlled delivery of isoxsuprine hydrochloride and be helpful in the future treatment of peripheral vascular disease.
Keywords: Isoxsuprine hydrochloride, HPMC K15, Gaur Gum, PVP K30, Direct compression method, Dissolution
2. Advanced oral and parenteral drug delivery technologies: Players, products & prospects to 2015. Dublin: Espicom Business Intelligence Ltd, 2011.
3. Charman SA, Charman W. Oral modified-release delivery systems. In: Rathbone MJ Hadgraft J, Roberts MS (eds.). Modified-release drug delivery technology. New York: Marcel Dekker, 2002. Chap. 1.
4. Moodley K, Pillary V, Choonara YE, Toit LC, Ndesendo VMK, Kumar P et al. Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery. Int J Mol Sci 2012; 13:18-43.
5. Malmsten M. Surfactants and polymers in drug delivery. Stockholm: Marcel Dekker, 2002. 335p.
6. Qiu LY, Bae YH. Polymer architecture and drug delivery. Pharmac Res 2006; 23(1):1-30.
7. Fukuda M, Peppas NA, McGinity JW. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. Int J Pharm 2006; 310: 90-100.
8. Damien G, Barochez BH, Schiavi P. Galenic development and pharmacokinetic profile of indapamide sustained release 1.5 mg. Clin Pharmacokinet 1999; 1: 13-19.
9. Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodrigez F, Heinamaki J. Development and optimization of a novel sustained release dextran tablet formulation for propranolol hydrochloride. Int J Pharm 2006; 317(1): 32-39.
10. Lopez CM, Lobo JMS, Pinto JF, Costa P. Compressed mini tablets as a biphasic delivery system. Int J Pharm 2006; 323: 93-100.
11. Varshosaz J, Tavakoli N, Eram SA. Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets. Drug Del 2006; 13(2): 113-119.
12. Sakore S, Chakraborty B. Formulation and evaluation of enalapril maleate sustained release matrix tablets. Int J Pharm Biomed Res 2013; 4:21-6.
13. Udayakumar T, Suresh AG, Ubaidulla U. Formulation and evaluation of immediate and sustained release bilayered tablet with glibenclamide and metformin Hcl. Int J Res Dev Pharm Sci 2013;2:337-43.
14. Shashidhar P, Vidya Sagar G, Srikanth G. Design and in-vitro evaluation of metformin hydrochloride (SR) and glimepiride (IR) as bilayered tablets. Int J Pharm Chem Sci 2013; 2:780-92.
15. Sridhar Babu G, Vijay Kumar D, Aishwarya M, Malathy PS, Redya Naik R. Formulation and in vitro characterization of sustained release matrix tablets of metformin HCl. J Glob Trends Pharm Sci 2014;5:2085-92.
16. Saluja V, Garg C. Once-daily sustained-release matrix tablets of metformin hydrochloride based on an enteric polymer and chitosan. J Pharm Educ Res 2013; 4:92-7.
17. Salsa T, Veiga F, Pina ME. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm. 1997; 23:929-938.
18. Apparao P, Jyothi VP, Raju J, Shashidher B. Formulation and evaluation of gum based matrix tablets of Lamivudine. Der Pharmacia Sinica, 2011; 2 (3): 176-192.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).